Showing results (891-900 of 919) with videos related to

Sort By:
Pageof 92
Oncotarget|December 22, 2017
The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapyKentaro Miyake, Takashi Murakami, Tasuku Kiyuna, et al.
Oncotarget|June 11, 2016
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Arun S Singh, Tasuku Kiyuna, et al.
Signal Transduction and Targeted Therapy|May 2, 2018
Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapyKentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Tissue & Cell|October 13, 2018
Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Anticancer Research|December 8, 2019
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug TherapyMasataka Oneyama, Naoya Sakamoto, Naohide Oue, et al.
Oncotarget|April 14, 2017
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Shukuan Li, Qinghong Han, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 10, 2023
Initial multicenter clinical experience with the first-generation endoscopic guided laser balloon in JapanMasahiko Goya, Kenzo Hirao, Kazutaka Aonuma, et al.
Journal of Arrhythmia|September 29, 2025
Prospective Multicenter Registry to Investigate the Clinical Feasibility of Combination Workflow With 90 W/4 s and Ablation Index-Guided 50 W Ablation (PRECISE-COMBO 90 W/50 W Study)Yuji Saito, Ryuta Watanabe, Koichi Nagashima, et al.
Chemotherapy|January 24, 2019
Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft ModelKentaro Miyake, Tasuku Kiyuna, Shukuan Li, et al.
Iscience|June 24, 2026
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft modelRyuta Sobu, Yuka Kobayashi, Soki Kashima, et al.
Pageof 92